Please assess the completion status of the following clinical trial:

Trial Title: Indomethacin Versus Nifedipine for Preterm Labor Tocolysis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE1/PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Singleton and twin gestations~* Intact amniotic membranes~* No contra-indications to tocolysis~* 24-34 weeks gestation by last menstrual period and/or ultrasound~* Documented cervical change, and regular painful uterine contractions at least every 5 minutes, or at least 2 cm cervical dilation and 80% effacement~Exclusion Criteria:~* Ruptured amniotic membranes~* Signs/symptoms of chorioamnionitis (maternal temperature greater than 100.4 F/38.0 C, fetal tachycardia, uterine tenderness)~* Non-reassuring fetal heart rate tracings~* Contra-indications to indomethacin or nifedipine~* Contra-indications to tocolysis

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Indomethacin (Type: ACTIVE_COMPARATOR): 50 mg. oral Indomethacin initially, followed by 25 mg every 6 hrs for 48 hrs.
- Nifedipine (Type: ACTIVE_COMPARATOR): 30 mg Nifedipine initially followed by 20 mg every 6 hrs for 48 hrs.

Based on this trial design, predict the completion outcome and termination type (if applicable).